Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
1987 | Importance of FSH releasing protein and inhibin in erythro¬differentiation | Yu, J.; Shao, L.; Lemas, V.; Yu, A. L.; Vaughan, J.; Rivier, J.; Vale, W. | Nature 330, 765-767 | | | |
2000 | In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxy staurosporine) in dependent on p16 protein status: a pediatric oncology group study | Omura-Minamisawa, M.; Diccianni, M. B.; Batova, A.; Chang, R. C.; Bridgeman, L. J.; Yu, J.; de Wit, E.; Kung, F. H.; Pullen, J.; Yu, A. L. | Cancer Res 60, 6573-6576 | | | |
1989 | Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase | Yu, J.; Lemas, V.; Page, T.; Connor, D.; Yu, A. L. | Cancer Res 49, 5555-5560 | | | |
2010 | Mesenchymal stem cell-like characteristics of human phyllodes tumors. | Lin, JJ; Yu, J; Huang, CS; Yeh, KT; Lien, HC; Chou, FP; Chang, WY; Yu, A. L. | | | | |
1985 | Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin | Matsumoto, S.; Yu, A. L.; Yu, J. | Cancer Investigation 3, 225-233 | | | |
2008 | MPDA: microarray pooled DNA analyzer | Yang, H. C.; Huang, M. C.; Li, L. H.; Lin, C. H.; Yu, A. L.; Diccianni, M. B.; Wu, J. Y.; Chen, Y. T.; Fann, C. S. J. | BMC Bioinformatics 9, 196 | | | |
2001 | Preconditioning with fetal cord blood facilitates engraftment of primary childhood T-cell acute lymphoblastic leukemia in immunodeficient mice | Dialynas, D. P.; Lee, M. J.; Gold, D. P.; Shao, L. E.; Yu, A. L.; Borowitz, M. J.; Yu, J. | Blood 97, 3218-3225 | | | |
1997 | Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: Its therapeutic implication for MTAP (-) malignancies | Yu, J.; Batova, A.; Shao, L. E.; Carrera, C. J.; Yu, A. L. | Clin. Cancer Res 3, 433-438 | | | |
1997 | Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions | Diccianni, M. B.; Batova, A.; Yu, J.; Vu, T.; Pullen, J.; Amylon, M.; Pollock, B.; Yu, A. L. | Leukemia Res 21, 549-558 | | | |
2012 | Structure-based design of cancer- targeting peptides for therapy and imaging | Wang, S. H.; Chen, I. J.; Chang, N. C.; Yu, A. L.; Wu, H. C.; Yu, H. M.; Chang, Y. J.; Lee, T. W.; Yu, J. C.; Lee, A. C-L; Yu, J. | NATURE BIOTECHNOLOGY | | | |
2012 | Surface markers in stem cells and cancer from the perspective of glycomic analysis | Cho, H. C.; Liao, C. H.; Yu, A. L.; Yu, J. | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 27(4):344 - 352 | | | |
2002 | The histone deacetylase inhibitor AN-9 has selective toxicity to drug-resistant primary leukemia and cancer cell lines | Batova, A.; Shao, L. E.; Diccianni, M. B.; Yu, A. L.; Tanaka, T.; Rephaeli, A.; Nudelman, A.; Yu, J. | Blood 100, 3319-3324 | | | |
2001 | Thioredoxin expression in primary childhood T-cell acute lymphoblastic leukemia and its therapeutic implications | Shao, L. E.; Diccianni, M. B.; Tanaka, T.; Yu, A. L.; Bessent, E.; Pullen, J.; Yu, J. | Cancer Res 61, 7333-7338 | | | |
2000 | Universal inactivation of both p16 and p15 but not downstream components is an essential event in pathogenesis of T-cell acute lymphoblastic leukemia | Omura-Minamisawa, M.; Diccianni, M. B.; Batova, A.; Chang, R. C.; Bridgeman, L.; Yu, J.; Pullen, J.; Bowman, W. P.; Yu, A. L. | CLINICAL CANCER RESEARCH 6, 1219-1228 | | | |
1999 | Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro | Batova, A.; Diccianni, M. B.; Yu, J.; Carrera, C. J.; Bridgeman, L. J.; Kung, F. H.; Pullen, J.; Amylon, M. D.; Yu, A. L. | Cancer Research 59, 1492-1497 | | | |